Skip to main content
Erschienen in: World Journal of Urology 11/2015

01.11.2015 | Original Article

Which is better? Guy’s versus S.T.O.N.E. nephrolithometry scoring systems in predicting stone-free status post-percutaneous nephrolithotomy

verfasst von: Yasser A. Noureldin, Mohamed A. Elkoushy, Sero Andonian

Erschienen in: World Journal of Urology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction and objective

The aim of the present study was to compare the accuracy of the Guy’s and S.T.O.N.E. scoring systems in predicting percutaneous nephrolithotomy (PCNL) outcomes.

Methods

After obtaining ethics approval, medical records of patients undergoing PCNL between 2009 and 2013 at a tertiary stone center were retrospectively reviewed. Guy’s and S.T.O.N.E. scoring systems were calculated. Regression analysis and ROC curves were performed.

Results

A total of 185 PCNLs were reviewed. The overall stone-free rate was 71.9 % with a complication rate of 16.2 %. When compared to patients with residual fragments, stone-free patients had significantly lower Guy’s grade (2.7 vs. 2; p < 0.001) and S.T.O.N.E. score (8.3 vs. 7.4; p = 0.004). Logistic regression analysis showed that both Guy’s and S.T.O.N.E. systems were significantly associated with stone-free status, OR 0.4 (p < 0.001), and OR 0.7 (p = 0.001), respectively. Furthermore, both scoring systems were significantly associated with the estimated blood loss (p = 0.01 and p = 0.005). There was good correlation between both scoring systems and operative time (r = 0.3, p < 0.001 and r = 0.4, p < 0.001) and length of hospital stay (r = 0.2, p = 0.001 and r = 0.3, p < 0.001). However, there were no significant associations between both scoring systems and complications (p = 0.7 and p = 0.6). There was no significant difference in the areas under the curves for the Guy’s and S.T.O.N.E. scoring systems (0.74 [95 % CI 0.66–0.82] vs. 0.63 [95 % CI 0.54–0.72]; p = 0.06).

Conclusion

Both Guy’s and S.T.O.N.E scoring systems have comparable accuracies in predicting post-PCNL stone-free status. Other factors not included in either scoring system may need to be incorporated in the future to increase their accuracy.
Literatur
1.
Zurück zum Zitat Preminger GM, Assimos DG, Lingeman JE et al (2005) AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000CrossRefPubMed Preminger GM, Assimos DG, Lingeman JE et al (2005) AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000CrossRefPubMed
2.
Zurück zum Zitat Mirheydar HS, Palazzi KL, Derweesh IH, Chang DC, Sur RL (2013) Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. Journal of endourology/Endourological Society 27(8):979–983CrossRefPubMed Mirheydar HS, Palazzi KL, Derweesh IH, Chang DC, Sur RL (2013) Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. Journal of endourology/Endourological Society 27(8):979–983CrossRefPubMed
4.
Zurück zum Zitat Thomas K, Smith NC, Hegarty N et al (2011) The Guy’s stone score-grading the complexity of percutaneous nephrolithotomy procedures. Urology 78(2):277–281CrossRefPubMed Thomas K, Smith NC, Hegarty N et al (2011) The Guy’s stone score-grading the complexity of percutaneous nephrolithotomy procedures. Urology 78(2):277–281CrossRefPubMed
5.
Zurück zum Zitat Vicentini FC, Marchini GS, Mazzucchi E et al (2014) Utility of the Guy’s stone score based on computed tomographic scan findings for predicting percutaneous nephrolithotomy outcomes. Urology 83(6):1248–1253CrossRefPubMed Vicentini FC, Marchini GS, Mazzucchi E et al (2014) Utility of the Guy’s stone score based on computed tomographic scan findings for predicting percutaneous nephrolithotomy outcomes. Urology 83(6):1248–1253CrossRefPubMed
6.
Zurück zum Zitat Ingimarsson JP, Dagrosa LM, Hyams ES et al (2014) External validation of a preoperative renal stone grading system: reproducibility and inter-rater concordance of the Guy’s stone score using preoperative computed tomography and rigorous postoperative stone-free criteria. Urology 83(1):45–49CrossRefPubMed Ingimarsson JP, Dagrosa LM, Hyams ES et al (2014) External validation of a preoperative renal stone grading system: reproducibility and inter-rater concordance of the Guy’s stone score using preoperative computed tomography and rigorous postoperative stone-free criteria. Urology 83(1):45–49CrossRefPubMed
7.
Zurück zum Zitat Okhunov Z, Friedlander JI, George AK et al (2013) S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi. Urology 81(6):1154–1159CrossRefPubMed Okhunov Z, Friedlander JI, George AK et al (2013) S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi. Urology 81(6):1154–1159CrossRefPubMed
8.
Zurück zum Zitat Okhunov Z, Helmy M, Perez-Lansac A et al (2013) Interobserver reliability and reproducibility of S.T.O.N.E. nephrolithometry for renal calculi. J Endourol 27(10):1303–1306CrossRefPubMed Okhunov Z, Helmy M, Perez-Lansac A et al (2013) Interobserver reliability and reproducibility of S.T.O.N.E. nephrolithometry for renal calculi. J Endourol 27(10):1303–1306CrossRefPubMed
9.
Zurück zum Zitat Shahrour W, Andonian S (2010) Ambulatory percutaneous nephrolithotomy: initial series. Urology 76:1288–1292CrossRefPubMed Shahrour W, Andonian S (2010) Ambulatory percutaneous nephrolithotomy: initial series. Urology 76:1288–1292CrossRefPubMed
10.
Zurück zum Zitat de la Rosette JJ, Opondo D, Daels FP, CROES PCNL Study Group et al (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62(2):246–255CrossRefPubMed de la Rosette JJ, Opondo D, Daels FP, CROES PCNL Study Group et al (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62(2):246–255CrossRefPubMed
12.
Zurück zum Zitat Mandal S, Goel A, Kathpalia R et al (2012) Prospective evaluation of complications using the modified Clavien grading system, and of success rates of percutaneous nephrolithotomy using Guy’s Stone Score: a single-center experience. Indian J Urol 28(4):392–398PubMedCentralCrossRefPubMed Mandal S, Goel A, Kathpalia R et al (2012) Prospective evaluation of complications using the modified Clavien grading system, and of success rates of percutaneous nephrolithotomy using Guy’s Stone Score: a single-center experience. Indian J Urol 28(4):392–398PubMedCentralCrossRefPubMed
Metadaten
Titel
Which is better? Guy’s versus S.T.O.N.E. nephrolithometry scoring systems in predicting stone-free status post-percutaneous nephrolithotomy
verfasst von
Yasser A. Noureldin
Mohamed A. Elkoushy
Sero Andonian
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 11/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1508-5

Weitere Artikel der Ausgabe 11/2015

World Journal of Urology 11/2015 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.